APA (7th ed.) Citation

Bai, F., Beringheli, T., Vitaletti, V., Santoro, A., Molà, F., Copes, A., . . . Bini, T. (2024). Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir. Infectious Diseases & Therapy, 13(7), 1589. https://doi.org/10.1007/s40121-024-00994-3

Chicago Style (17th ed.) Citation

Bai, Francesca, et al. "Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir." Infectious Diseases & Therapy 13, no. 7 (2024): 1589. https://doi.org/10.1007/s40121-024-00994-3.

MLA (9th ed.) Citation

Bai, Francesca, et al. "Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir." Infectious Diseases & Therapy, vol. 13, no. 7, 2024, p. 1589, https://doi.org/10.1007/s40121-024-00994-3.